MEDMARK LLC – Trademark Portfolio
Entity Type: 16
MEDMARK LLC holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 25 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 17 trademarks are registered and 5 are pending. Notable registered marks include NUTESTA, SERELAX, SOMULIN, ZENOFEM, and BONEXCIN. The owner is based in CARSON CITY, NV.
123 W. NYE LANE, SUITE 129
CARSON CITY, NV 89706
Showing of trademarks Trademarks
Trademark Classifications
MEDMARK LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does MEDMARK LLC have?
MEDMARK LLC has 27 U.S. trademarks filed with the USPTO. Of these, 17 registered, 5 pending, 2 abandoned, 3 cancelled.
What trademark classes does MEDMARK LLC file in?
MEDMARK LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MEDMARK LLC's most well-known trademarks?
MEDMARK LLC's registered trademark portfolio includes well-known marks such as NUTESTA, SERELAX, SOMULIN, ZENOFEM, and BONEXCIN. These are among 17 currently registered trademarks in the portfolio.
What is MEDMARK LLC's trademark registration success rate?
MEDMARK LLC has a 77% trademark registration rate, with 17 out of 22 resolved applications resulting in successful registration. Currently, 5 applications are pending review.